Gur-Cetinkaya, P. Et Al. 2018. Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss. TURKISH JOURNAL OF PEDIATRICS , vol.60, no.3 , 270-276.

Gur-Cetinkaya, P., Cagdas-Ayvaz, D. N., Oksuz, A. B., Ertoy, A., Hayran, U., Ozkan, F., ... Erol, M.(2018). Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss. TURKISH JOURNAL OF PEDIATRICS , vol.60, no.3, 270-276.

Gur-Cetinkaya, PINAR Et Al. "Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss," TURKISH JOURNAL OF PEDIATRICS , vol.60, no.3, 270-276, 2018

Gur-Cetinkaya, PINAR G. Et Al. "Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss." TURKISH JOURNAL OF PEDIATRICS , vol.60, no.3, pp.270-276, 2018

Gur-Cetinkaya, P. Et Al. (2018) . "Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss." TURKISH JOURNAL OF PEDIATRICS , vol.60, no.3, pp.270-276.

@article{article, author={PINAR GÜR ÇETİNKAYA Et Al. }, title={Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss}, journal={TURKISH JOURNAL OF PEDIATRICS}, year=2018, pages={270-276} }